Splash Beverage Group (EDVA)
Distributor of Chispo tequila and developer of a licensed cannabinoid epilepsy treatment.
Something off on this page? Send us feedback.
Distributes Chispo tequila through independent distributors while shifting from a former beverage portfolio toward a licensed cannabinoid epilepsy program. U.S. CannEpil commercialization depends on clinical trials, regulatory approval, and its Argent license.
Distributes Chispo, a blue-agave blanco tequila made in Jalisco, Mexico, through independent distributors in certain U.S. states and international markets. Sales are currently concentrated in on-premise hospitality, including Señor Frog's locations in Florida, the Bahamas, and Mexico.
Is shifting from its former multi-brand beverage portfolio toward regulated cannabinoid wellness and pharmaceutical development. Its exclusive worldwide CannEpil license covers a CBD-and-THC formulation for drug-resistant epilepsy, while its Avicanna holding is a minority investment and Medterra remains a proposed transaction.
Commercializing CannEpil in the United States requires clinical trials and a new drug application. Argent is the expected manufacturer and receives a royalty on net revenue, tying the program to clinical, regulatory, financing, and licensor-manufacturer execution.
Company facts
No analyst consensus on record.
EPSReportedEstimate
RevenueReportedEstimate
Balance sheet, Jun 30, 2026Cash & short-term investments $242.7K · Total debt $6.4M · Total assets $1.1M · Shareholders' equity −$15.7M
- Revenue
- $0
- Operating income
- −$2.0M
- Net income
- −$2.1M
No dividends on record.
| Institutions | 2.65% | 170.0K shares | |
|---|---|---|---|
| 15 holders · as of Mar 31, 2026 | |||
| Other | 97.35% | 6.24M shares | |
| remainder | |||
6.41M company shares as of Sep 5, 2026 · institutions as of Mar 31, 2026 · holders as of their latest filing
Top shareholders13F · 13D/G · Form 4
| Holder | Stake | Shares | Date |
|---|---|---|---|
HRT Financial LPInstitution | 0.52% | 134,456 | as of Mar 31, 2026 |
Virtu Financial LLCInstitution | 0.39% | 100,185 | as of Mar 31, 2026 |
Summit Trail Advisors, LLCInstitution | 0.39% | 100,000 | as of Mar 31, 2026 |
Phraction Management LLCInstitution | 0.27% | 70,000 | as of Mar 31, 2026 |
Lifetime Wealth Management P.C.Institution | 0.26% | 66,050 | as of Mar 31, 2026 |
Insider tradesForm 4
Nothing filed in the last 12 months.
- Diageo (ADR)
Premium tequila portfolio in on-premise and distributor placements.
- Jazz Pharmaceuticals
Approved cannabinoid epilepsy therapy for CannEpil's intended population.
CompareAfter hours
| Company | Price | Change | |||||
|---|---|---|---|---|---|---|---|
| Splash Beverage Group | $0.3588 | +54.66% | $1.5M | — | — | — | +863.8% |
| Diageo (ADR) | $87.37 | 0.00% | $48.26B | 27.8 | — | 2.5 | −1.7% |
| Jazz Pharmaceuticals | $240.57 | 0.00% | $15.17B | 16.5 | 9.5 | 3.3 | +15.6% |
| Median | 22.2 | 9.5 | 2.9 | +6.9% |